NCT00946946 Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine Status COMPLETED Phase PHASE3
NCT00944736 Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease Status COMPLETED Phase PHASE3
NCT00936585 NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease Status TERMINATED Phase NA
NCT00917514 An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen Status COMPLETED Phase N/A
NCT00899678 The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents Status TERMINATED Phase PHASE2
NCT00851565 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Status UNKNOWN Phase PHASE4
NCT00838149 Effect of Glutamine on Intestinal Permeability in Crohn's Disease Status COMPLETED Phase PHASE1
NCT00819663 Intestinal Wall Remodeling (Infliximab Therapy) in Crohn's Disease Patients Undergoing Serial Computed Tomography (CT) Enterography Status COMPLETED Phase N/A
NCT00818272 Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED) Status COMPLETED Phase N/A
NCT00815061 Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population Status WITHDRAWN Phase N/A
NCT00810030 FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR Status COMPLETED Phase PHASE3
NCT00808262 Safety and Immunogenicity of a TNFa Kinoid in Patients With Crohn's Disease Status COMPLETED Phase PHASE1/PHASE2
NCT00805766 Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD) Status COMPLETED Phase PHASE3
NCT00801125 Study of Tysabri (Natalizumab) in Patients Who Failed Anti-TNF-α Therapy Status WITHDRAWN Phase PHASE4
NCT00796250 Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732) Status TERMINATED Phase PHASE3
NCT00792740 Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease Status TERMINATED Phase PHASE1/PHASE2